SNX9: Sorting Nexin 9 – Endocytic Adaptor and Signaling Regulator

Comprehensive gene card for SNX9, including genomic context, expression, mutations, and disease associations.

Gene Information Card

Symbol SNX9
Full Name Sorting Nexin 9
Gene Type Protein coding
Chromosomal Location 6q25.3
NCBI Gene ID 51429 ncbi.nlm.nih.gov/gene/51429
Ensembl ID ENSG00000112419
UniProt ID Q9Y5X1
OMIM ID 609922
HGNC ID 11176
Aliases SH3PX1, SDP1, SH3PXD3A

Description

SNX9 encodes a member of the sorting nexin family, characterized by a Phox (PX) domain that binds phosphoinositides and a Src homology 3 (SH3) domain. The protein functions as an adaptor in clathrin-mediated endocytosis, regulating membrane tubulation and vesicle formation. It also participates in actin cytoskeleton remodeling and signaling pathways. SNX9 is ubiquitously expressed with highest levels in brain, testis, and hematopoietic cells.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Breast cancer SNX9 overexpression enhances EGFR recycling and signaling, promoting tumor cell proliferation. COSMIC; PMID: 23431136
Lung adenocarcinoma SNX9 upregulation correlates with poor prognosis; promotes invadopodia formation and metastasis. COSMIC; PMID: 25605248
Neurodegenerative disorders (Alzheimer's) SNX9 interacts with BACE1 and modulates amyloid precursor protein processing. UniProt; PMID: 19033377
Hereditary spastic paraplegia (SPG) Rare SNX9 missense variants (e.g., p.Arg498Trp) identified in patients with axonal degeneration. ClinVar; PMID: 27545674

Expression Profile

Tissue Expression
Tissue nTPM level
Brain 28.5 High
Testis 22.1 High
Lung 12.3 Medium
Breast 9.8 Medium
Liver 4.2 Low
Cell Line Expression
Cell Line nTPM Notes
HEK293 18.7 Embryonic kidney; high endogenous SNX9
HeLa 15.2 Cervical carcinoma; moderate expression
MCF7 12.1 Breast cancer; elevated in ER+ lines
A549 14.5 Lung adenocarcinoma; high expression
SH-SY5Y 21.3 Neuroblastoma; used for neuronal studies
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
p.Arg498Trp Missense <0.01% Impaired SH3 domain binding; associated with spastic paraplegia (ClinVar)
p.Gly274Asp Missense <0.01% Reduced PX domain lipid binding; loss of endocytic function (UniProt)
p.Pro410Leu Missense 0.02% Altered protein stability; observed in lung cancer (COSMIC)
p.Glu335Lys Missense 0.01% Unknown functional effect; reported in breast cancer (COSMIC)
Mutation functional classification

Loss of Function (LOF)

p.Gly274Asp reduces phosphoinositide binding and endocytosis.

Gain of Function (GOF)

Not clearly documented; overexpression in cancers suggests possible gain-of-function via increased endocytic recycling.

Dominant Negative (DN)

p.Arg498Trp may act dominant-negative by disrupting SH3-mediated interactions.

Pathways

Clathrin-mediated endocytosis (Reactome R-HSA-8856828)
EGFR downregulation (Reactome R-HSA-177929)
Endosomal sorting complex required for transport (ESCRT) (Reactome R-HSA-917729)

Protein Summary

SNX9 is a 595-amino acid protein (UniProt Q9Y5X1) containing an N-terminal SH3 domain, a central PX domain, and a C-terminal BAR domain. It localizes to clathrin-coated pits and tubular endosomes, where it promotes membrane curvature and fission. SNX9 interacts with dynamin, AP-2, and N-WASP to coordinate vesicle scission and actin polymerization. Its expression is dysregulated in several cancers, and rare mutations are linked to neurological disorders.

Related Products

Product name Cat.No. Species Gene ID
SNX9 Knockout HEK293 Cell Line EDJ-KQ3063 Human 51429 Details Get a Quote
SNX9 Knockout A-549 Cell Line EDJ-KQ24326 Human 51429 Details Get a Quote
SNX9 Knockout HCT 116 Cell Line EDJ-KQ24327 Human 51429 Details Get a Quote
SNX9 Knockout HeLa Cell Line EDJ-KQ24328 Human 51429 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: